BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Sunovion Pharmaceuticals Inc. 

84 Waterford Drive

Marlborough  Massachusetts  01752  U.S.A.
Phone: 508-481-6700 Fax:


SEARCH JOBS

View Clinical Trials from BioPharm Insight





Collaborations

ACADIA Pharmaceuticals, Inc.  ACADIA has formed a broad CNS collaboration with Sepracor for the discovery and development of new drug candidates against muscarinic receptors.

Cubist Pharmaceuticals, Inc. 





 Company News
Sunovion Pharmaceuticals Inc. Announces Data Published In The CHEST Journal From A One-Year, Large Simple Safety Study Evaluating BROVANA® (Arformoterol Tartrate) Inhalation Solution 7/8/2014 7:21:21 AM
FDA Slashes Starting Dose For Sunovion Pharmaceuticals Inc.'s Lunesta; Warns Risk Of Next-Day Impairment 5/15/2014 3:17:45 PM
Sunovion Pharmaceuticals Inc. Release: Once-Daily Aptiom® (Eslicarbazepine Acetate) For The Adjunctive Treatment Of Partial-Onset Seizures Now Available In U.S. Pharmacies 4/7/2014 10:15:05 AM
Sunovion Pharmaceuticals Inc. And Takeda Announce Results From A New Study Showing Maintenance Treatment With Lurasidone Reduced The Risk Of Relapse In Adults With Schizophrenia 3/3/2014 8:36:35 AM
Sunovion Pharmaceuticals Inc. Presents Positive Results From Two Phase 3 Studies Of Once-Daily Aptiom® (Eslicarbazepine Acetate) As Monotherapy Treatment For Partial-Onset Seizures 12/9/2013 10:02:58 AM
Sunovion Pharmaceuticals Inc. Presents Phase 3 Pooled Analysis Of Once-Daily Aptiom® (Eslicarbazepine Acetate) As Adjunctive Treatment For Partial-Onset Seizures 12/9/2013 10:01:54 AM
Sunovion Pharmaceuticals Inc. To Present New Data On Aptiom® (eslicarbazepine acetate) At The American Epilepsy Society’s 67th Annual Meeting 12/9/2013 7:15:26 AM
Sunovion Pharmaceuticals Inc.., The COPD Foundation And Caring.com Join Forces To Support COPD Family Caregivers 11/18/2013 10:01:09 AM
Sunovion Pharmaceuticals Inc. Announces Publication of Two Pivotal Studies Supporting FDA Approval of Latuda® (lurasidone HCl) as Monotherapy and Adjunctive Therapy in Adult Patients With Bipolar Depression in The American Journal of Psychiatry 11/1/2013 9:50:42 AM
Sunovion Pharmaceuticals Inc. Presents Data at CHEST 2013 from a One-year, Large Simple Safety Study of BROVANA® (arformoterol tartrate) Inhalation Solution 10/29/2013 7:57:49 AM
12345678910...